Ali Niak, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Proton Pump Inhibitor Use in Infants: FDA Reveiwer Experience
Journal of Pediatric Gastroenterology and Nutrition
Volume: 54
Date: 01 2012

Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
Pharmacy and Therapeutics
Volume: 28
Date: 11 2015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647172/

Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database
Contraception
Volume: 96
Date: 08 2017
https://doi.org/10.1016/j.contraception.2017.08.009

Acute cholecystitis associated with the use of glucagon-like peptide agonists reported to the US Food and Drug Administration
JAMA
182, Number 10
Date: 10 2022
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2795476

Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients
JAMA
331, Number 6
Date: 01 2024
https://jamanetwork.com/journals/jama/fullarticle/2814249